{"id":386354,"date":"2020-07-30T00:00:00","date_gmt":"2020-07-30T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ep0063-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-asia-pacific-2021\/"},"modified":"2026-04-24T05:06:07","modified_gmt":"2026-04-24T05:06:07","slug":"m360ep0063-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-asia-pacific-2021","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360ep0063-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-asia-pacific-2021\/","title":{"rendered":"Electrophysiology Mapping and Ablation Devices | Market Insights | Asia Pacific | 2021"},"content":{"rendered":"<p>Growing\u00a0AF\u00a0treatment volumes, driven by an expanding patient pool, rising awareness of ablation procedures, and improving access to health care, will fuel strong growth in the Asia Pacific\u00a0EP\u00a0mapping and ablation device market through 2029.\u00a0However, the\u00a0COVID-19\u00a0global pandemic will have an impact on the Asia Pacific\u00a0EP\u00a0mapping and ablation\u00a0device market, resulting in lost procedure volumes in the short term followed by a period of recovery. This is expected to reduce the growth of the\u00a0EP\u00a0mapping and ablation device market.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for\u00a0EP\u00a0mapping and ablation devices\u00a0in Asia Pacific\u00a0across a 10-year period.<\/p>\n","protected":false},"template":"","class_list":["post-386354","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-electrophysiology-mapping-and-ablation-devices","medtech-geography-asia-pacific","medtech-date-945"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386354\/revisions"}],"predecessor-version":[{"id":387863,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/386354\/revisions\/387863"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=386354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}